China Health Labs & Diagnostics Ltd. Announces Conference Call to Discuss Results of the Second Quarter Ended June 30, 2012
August 23 2012 - 8:00AM
PR Newswire (Canada)
Financial Results for the Second Quarter Ended June 30, 2012 to be
Released on August 28, 2012 TORONTO, Aug. 23, 2012 /CNW/ - China
Health Labs & Diagnostics Ltd. ("China Health" or the
"Company") , is pleased to announce that it will be releasing the
results of the second quarter ended June 30, 2012 on August 28,
2012 after market close, and will be hosting an investor conference
call on Wednesday, August 29, 2012 at 10:00am (Eastern Time). The
purpose of this conference call will be to provide investors with
an update of the second quarter results of the Company.
Representing China Health on the conference call will be: Mr.
Shiping (Wilson) Yao, President and Chief Executive Officer Ms.
Judyanna Chen, Chief Financial Officer Mr. Kim Oishi, Member of the
Board of Directors Mr. Chao Zhang, Vice President, Finance
Following the update, a question and answer session will be
held. To participate, the dial-in instructions are as
follows: DATE: Wednesday, August 29, 2012
TIME: 10:00am, Eastern Time Participant Dial-In
Number(s): North America Toll-Free Dial-In Number: 1 (888) 231-8191
For Toronto and International Callers: 1 (647) 427-7450 A Taped
Replay will be available from 1:00 pm Eastern Time on August 29,
2012 to 11:59 pm Eastern Time on September 12, 2012. Taped Replay
Toll Free Number: 1.855.859.2056 Taped Replay Local Dial-in
Numbers: (778) 371-8506 (416) 849-0833 (514) 807-9274 (403)
451-9481 (613) 667-0035 (902) 455-3955 Taped Replay Password:
23951000 About China Health Labs & Diagnostics Ltd. China
Health, operating in China as the Biochem Group, is a leading
diagnostic lab solution provider for the public healthcare industry
in China. The Company develops and sells Biochem Group branded and
third-party medical diagnostic products and services to diagnostic
facilities in China. Customers include large urban hospitals, rural
hospitals, Chinese defense and rescue operations, the Beijing
government and third-party distributors. The Company intends to
continue to expand its business by focusing its efforts on
expanding its sales network in three areas where it provides
proprietary solutions, has limited competition and which are
supported by Chinese government policies and budgets: BK Clinlab
total lab solutions for rural hospitals and clinics, POCT solutions
for military and emergency rescue services, and food safety
solutions for large cities in China. In 2011, China Health
increased its revenues by 35% to $45.6 million, and increased its
installed base of BK Clinlab total solution diagnostic labs ("BK
Clinlabs") from 210 locations at the start of 2011 to 833 rural
hospitals. In addition, the Company grew revenues from its
overall business in providing total lab solutions by 99% from 2010,
which increased gross margins to 44% in 2011 as compared to 39% in
2010. Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release. FORWARD LOOKING INFORMATION This press
release contains forward-looking statements and information that
are based on the beliefs of management and reflect China Health's
current expectations. When used in this press release, the
words "estimate", "project", "belief", "anticipate", "intend",
"expect", "plan", "predict", "may" or "should" and the negative of
these words or such variations thereon or comparable terminology
are intended to identify forward-looking statements and
information. The forward-looking statements and information
in this press release includes information relating to the
expansion of the Company's business through its sales network in
areas where it has proprietary products, limited competition and
strong government support. The forward-looking information is
based on certain assumptions, which could change materially in the
future, including the assumption that the Company will be able to
expand its sales network and business. Such statements and
information reflect the current view of China Health with respect
to risks and uncertainties that may cause actual results to differ
materially from those contemplated in those forward-looking
statements and information. By their nature, forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or
achievements, or other future events, to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. Such factors include,
among others, the risk that the Company may not be able to expand
its business as expected through its sales network in any of the
areas in which it has proprietary products, limited competition and
strong government support. China Health cautions that the
foregoing list of material factors is not exhaustive. When
relying on China Health's forward-looking statements and
information to make decisions, investors and others should
carefully consider the foregoing factors and other uncertainties
and potential events. China Health has assumed a certain
progression, which may not be realized. It has also assumed
that the material factors referred to above will not cause such
forward-looking statements and information to differ materially
from actual results or events. However, the list of these
factors is not exhaustive and is subject to change and there can be
no assurance that such assumptions will reflect the actual outcome
of such items or factors. THE FORWARD-LOOKING INFORMATION CONTAINED
IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH
AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT
TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE
IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON
THIS INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY
ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY
PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE
LAWS. CHINA HEALTH LABS & DIAGNOSTICS CONTACT:
Judyanna ChenChief Financial OfficerChina Health Labs &
Diagnostics Ltd.T: (416) 865-3351Email:
jchen@chinahealthlabs.comBabak PedramInvestor RelationsTMX Equicom
GroupT: (416) 815-0700 ext. 264Email: bpedram@equicomgroup.com
Copyright
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jul 2023 to Jul 2024